Overview

Safety and Efficacy Study of a New Treatment for Symptoms of Urinary Incontinence

Status:
Completed
Trial end date:
2012-05-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine if a new drug treatment is effective for the treatment of symptoms of urinary incontinence.
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
Beech Tree Labs, Inc.
Collaborator:
Norwich Clinical Research Associates Ltd.